User profiles for Jienchi Dorward
 | Jienchi DorwardNuffield Department of Primary Care Health Sciences, University of Oxford Verified email at phc.ox.ac.uk Cited by 3141 |
[HTML][HTML] Risk of adverse coronavirus disease 2019 outcomes for people living with HIV
Objective: To assess whether people living with HIV (PLWH) are at increased risk of coronavirus
disease 2019 (COVID-19) mortality or adverse outcomes, and whether antiretroviral …
disease 2019 (COVID-19) mortality or adverse outcomes, and whether antiretroviral …
Point-of-care HIV viral load testing: an essential tool for a sustainable global HIV/AIDS response
The global public health community has set ambitious treatment targets to end the HIV/AIDS
pandemic. With the notable absence of a cure, the goal of HIV treatment is to achieve …
pandemic. With the notable absence of a cure, the goal of HIV treatment is to achieve …
[HTML][HTML] Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a …
Background There are few primary care studies of the COVID-19 pandemic. We aimed to
identify demographic and clinical risk factors for testing positive for severe acute respiratory …
identify demographic and clinical risk factors for testing positive for severe acute respiratory …
[HTML][HTML] Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an …
Background The safety, effectiveness, and cost-effectiveness of molnupiravir, an oral
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
antiviral medication for SARS-CoV-2, has not been established in vaccinated patients in the …
[HTML][HTML] Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label …
LM Yu, M Bafadhel, J Dorward, G Hayward, BR Saville… - The Lancet, 2021 - thelancet.com
Background A previous efficacy trial found benefit from inhaled budesonide for COVID-19 in
patients not admitted to hospital, but effectiveness in high-risk individuals is unknown. We …
patients not admitted to hospital, but effectiveness in high-risk individuals is unknown. We …
[HTML][HTML] The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis
J Dorward, T Khubone, K Gate, H Ngobese… - The lancet HIV, 2021 - thelancet.com
Background The effect of the COVID-19 pandemic on HIV outcomes in low-income and
middle-income countries is poorly described. We aimed to measure the impact of the 2020 …
middle-income countries is poorly described. We aimed to measure the impact of the 2020 …
[HTML][HTML] Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised …
Background Azithromycin, an antibiotic with potential antiviral and anti-inflammatory properties,
has been used to treat COVID-19, but evidence from community randomised trials is …
has been used to treat COVID-19, but evidence from community randomised trials is …
[HTML][HTML] Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled …
Background Doxycycline is often used for treating COVID-19 respiratory symptoms in the
community despite an absence of evidence from clinical trials to support its use. We aimed to …
community despite an absence of evidence from clinical trials to support its use. We aimed to …
Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research
A new first-line antiretroviral therapy (ART) regimen containing dolutegravir is being rolled
out in low-income and middle-income countries (LMICs). In studies from predominantly high-…
out in low-income and middle-income countries (LMICs). In studies from predominantly high-…
Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised …
PK Drain, J Dorward, LR Violette, J Quame-Amaglo… - The lancet HIV, 2020 - thelancet.com
Background Monitoring HIV treatment with laboratory testing introduces delays for providing
appropriate care in resource-limited settings. The aim of our study was to determine whether …
appropriate care in resource-limited settings. The aim of our study was to determine whether …